Synendos Therapeutics
Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.
Synendos Therapeutics has raised €19M across 1 funding round from 2 investors, most recently a Series A round in Nov 2020. Based in Allschwil, Switzerland; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€19M
€18,530,529
Funding rounds
1
Investors
2
distinct backers
Active since
2020-11
latest 2020-11
Funding by year
EUR raised per yearSynendos Therapeutics — funding by year — interactive chart.
Data table
| Synendos Therapeutics — funding by year | |
|---|---|
| 2020 | €19M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-12 | Series A | €19M | Kurma Partners,Sunstone Life Science Ventures | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData